These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21452188)

  • 21. Structure-activity relationships of a series of analogues of the RFamide-related peptide 26RFa.
    Le Marec O; Neveu C; Lefranc B; Dubessy C; Boutin JA; Do-Régo JC; Costentin J; Tonon MC; Tena-Sempere M; Vaudry H; Leprince J
    J Med Chem; 2011 Jul; 54(13):4806-14. PubMed ID: 21623631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Further studies on the pharmacological profile of the neuropeptide S receptor antagonist SHA 68.
    Ruzza C; Rizzi A; Trapella C; Pela' M; Camarda V; Ruggieri V; Filaferro M; Cifani C; Reinscheid RK; Vitale G; Ciccocioppo R; Salvadori S; Guerrini R; Calo' G
    Peptides; 2010 May; 31(5):915-25. PubMed ID: 20172007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects.
    Xu YL; Reinscheid RK; Huitron-Resendiz S; Clark SD; Wang Z; Lin SH; Brucher FA; Zeng J; Ly NK; Henriksen SJ; de Lecea L; Civelli O
    Neuron; 2004 Aug; 43(4):487-97. PubMed ID: 15312648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuropeptide S as a novel arousal promoting peptide transmitter.
    Reinscheid RK; Xu YL
    FEBS J; 2005 Nov; 272(22):5689-93. PubMed ID: 16279934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ligand affinity for amino-terminal and juxtamembrane domains of the corticotropin releasing factor type I receptor: regulation by G-protein and nonpeptide antagonists.
    Hoare SR; Sullivan SK; Schwarz DA; Ling N; Vale WW; Crowe PD; Grigoriadis DE
    Biochemistry; 2004 Apr; 43(13):3996-4011. PubMed ID: 15049707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuropeptide S and its receptor: a newly deorphanized G protein-coupled receptor system.
    Reinscheid RK; Xu YL
    Neuroscientist; 2005 Dec; 11(6):532-8. PubMed ID: 16282594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of the first biased NPS receptor agonist that retains anxiolytic and memory promoting effects with reduced levels of locomotor stimulation.
    Clark SD; Kenakin TP; Gertz S; Hassler C; Gay EA; Langston TL; Reinscheid RK; Runyon SP
    Neuropharmacology; 2017 May; 118():69-78. PubMed ID: 28267583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and evaluation of a new series of Neuropeptide S receptor antagonists.
    Melamed JY; Zartman AE; Kett NR; Gotter AL; Uebele VN; Reiss DR; Condra CL; Fandozzi C; Lubbers LS; Rowe BA; McGaughey GB; Henault M; Stocco R; Renger JJ; Hartman GD; Bilodeau MT; Trotter BW
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4700-3. PubMed ID: 20510609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of central neuropeptide S in the mouse formalin test.
    Peng YL; Zhang JN; Chang M; Li W; Han RW; Wang R
    Peptides; 2010 Oct; 31(10):1878-83. PubMed ID: 20603169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Receptor-specific functional efficacies of alkyl imidazoles as dual histamine H3/H4 receptor ligands.
    Kottke T; Sander K; Weizel L; Schneider EH; Seifert R; Stark H
    Eur J Pharmacol; 2011 Mar; 654(3):200-8. PubMed ID: 21237145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anatomical characterization of the neuropeptide S system in the mouse brain by in situ hybridization and immunohistochemistry.
    Clark SD; Duangdao DM; Schulz S; Zhang L; Liu X; Xu YL; Reinscheid RK
    J Comp Neurol; 2011 Jul; 519(10):1867-93. PubMed ID: 21452235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coumarinyl pyranopyrimidines as new neuropeptide S receptor antagonists; design, synthesis, homology and molecular docking.
    Batran RZ; Dawood DH; El-Seginy SA; Maher TJ; Gugnani KS; Rondon-Ortiz AN
    Bioorg Chem; 2017 Dec; 75():274-290. PubMed ID: 29055857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropeptide S: a new player in the modulation of arousal and anxiety.
    Reinscheid RK; Xu YL; Civelli O
    Mol Interv; 2005 Feb; 5(1):42-6. PubMed ID: 15731503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-function relationships in the neuropeptide S receptor: molecular consequences of the asthma-associated mutation N107I.
    Bernier V; Stocco R; Bogusky MJ; Joyce JG; Parachoniak C; Grenier K; Arget M; Mathieu MC; O'Neill GP; Slipetz D; Crackower MA; Tan CM; Therien AG
    J Biol Chem; 2006 Aug; 281(34):24704-12. PubMed ID: 16790440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-activity study at positions 3 and 4 of human neuropeptide S.
    Camarda V; Trapella C; Calo' G; Guerrini R; Rizzi A; Ruzza C; Fiorini S; Marzola E; Reinscheid RK; Regoli D; Salvadori S
    Bioorg Med Chem; 2008 Oct; 16(19):8841-5. PubMed ID: 18793857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2,4-diaminopyrimidine derivatives as potent growth hormone secretagogue receptor antagonists.
    Serby MD; Zhao H; Szczepankiewicz BG; Kosogof C; Xin Z; Liu B; Liu M; Nelson LT; Kaszubska W; Falls HD; Schaefer V; Bush EN; Shapiro R; Droz BA; Knourek-Segel VE; Fey TA; Brune ME; Beno DW; Turner TM; Collins CA; Jacobson PB; Sham HL; Liu G
    J Med Chem; 2006 Apr; 49(8):2568-78. PubMed ID: 16610800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The significance of 2-furyl ring substitution with a 2-(para-substituted) aryl group in a new series of pyrazolo-triazolo-pyrimidines as potent and highly selective hA(3) adenosine receptors antagonists: new insights into structure-affinity relationship and receptor-antagonist recognition.
    Cheong SL; Dolzhenko A; Kachler S; Paoletta S; Federico S; Cacciari B; Dolzhenko A; Klotz KN; Moro S; Spalluto G; Pastorin G
    J Med Chem; 2010 Apr; 53(8):3361-75. PubMed ID: 20307065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis of (3,4-dimethoxyphenoxy)alkylamino acetamides as orexin-2 receptor antagonists.
    Cole AG; Stroke IL; Qin LY; Hussain Z; Simhadri S; Brescia MR; Waksmunski FS; Strohl B; Tellew JE; Williams JP; Saunders J; Appell KC; Henderson I; Webb ML
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5420-3. PubMed ID: 18815029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The paraventricular nucleus of the hypothalamus is a neuroanatomical substrate for the inhibition of palatable food intake by neuropeptide S.
    Fedeli A; Braconi S; Economidou D; Cannella N; Kallupi M; Guerrini R; Calò G; Cifani C; Massi M; Ciccocioppo R
    Eur J Neurosci; 2009 Oct; 30(8):1594-602. PubMed ID: 19821837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distribution of neuropeptide S receptor mRNA and neurochemical characteristics of neuropeptide S-expressing neurons in the rat brain.
    Xu YL; Gall CM; Jackson VR; Civelli O; Reinscheid RK
    J Comp Neurol; 2007 Jan; 500(1):84-102. PubMed ID: 17099900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.